Olr419 inhibitors are a class of chemical compounds that specifically target and modulate the function of the Olr419 receptor, a member of the olfactory receptor (OR) family. Olfactory receptors are a large and diverse group of G protein-coupled receptors (GPCRs) predominantly known for their role in the detection of odor molecules. However, their expression is not limited to the olfactory epithelium; they are also found in various non-olfactory tissues, where they can play diverse roles in cellular signaling pathways. Olr419 inhibitors function by binding to the Olr419 receptor, effectively blocking or altering its natural ligand's ability to activate the receptor. This inhibition can lead to a cascade of downstream effects, influencing various intracellular signaling mechanisms such as cyclic AMP (cAMP) levels, calcium mobilization, and other second messenger systems.
The design and synthesis of Olr419 inhibitors require a deep understanding of the receptor's structure and function. These inhibitors are typically small molecules that can fit into the binding pocket of the Olr419 receptor, effectively competing with or displacing the natural ligands. Structural studies, such as X-ray crystallography and molecular modeling, are crucial in elucidating the binding interactions between Olr419 and its inhibitors. Furthermore, the development of Olr419 inhibitors often involves optimizing their specificity and affinity to ensure that they selectively target the Olr419 receptor without affecting other members of the olfactory receptor family or unrelated GPCRs. This selectivity is essential for accurately dissecting the physiological and biochemical roles of Olr419 in various tissues and for exploring the broader implications of olfactory receptors in non-olfactory systems. The study of Olr419 inhibitors thus represents an intriguing intersection of olfactory research, molecular pharmacology, and chemical biology, offering insights into the diverse functionalities of olfactory receptors beyond their traditional sensory roles.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $79.00 $416.00 | 1 | |
Beta-1 adrenergic receptor antagonist, can indirectly modulate GPCR signaling, potentially affecting Olr419. | ||||||
Chlorthalidone | 77-36-1 | sc-207427 | 25 mg | $243.00 | 1 | |
Diuretic, might influence GPCR signaling indirectly through fluid and electrolyte balance modulation, impacting Olr419. | ||||||
Furosemide | 54-31-9 | sc-203961 | 50 mg | $41.00 | ||
Loop diuretic, may affect GPCR signaling indirectly through diuretic action, impacting Olr419. | ||||||
Hydrochlorothiazide | 58-93-5 | sc-207738 sc-207738A sc-207738B sc-207738C sc-207738D | 5 g 25 g 50 g 100 g 250 g | $55.00 $240.00 $333.00 $562.00 $988.00 | ||
Thiazide diuretic, can influence GPCR signaling indirectly through diuretic effects, impacting Olr419. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Angiotensin II receptor blocker, could indirectly affect GPCR signaling, potentially impacting Olr419. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Non-selective beta-adrenergic receptor antagonist, can alter GPCR signaling, potentially impacting Olr419. | ||||||
Ramipril | 87333-19-5 | sc-205833 sc-205833A sc-205833B sc-205833C sc-205833D | 500 mg 1 g 2 g 5 g 10 g | $179.00 $245.00 $364.00 $733.00 $1254.00 | 1 | |
ACE inhibitor, might influence GPCR signaling indirectly through effects on the renin-angiotensin system, impacting Olr419. | ||||||
Telmisartan | 144701-48-4 | sc-204907 sc-204907A | 50 mg 100 mg | $72.00 $94.00 | 8 | |
Angiotensin II receptor blocker, could modulate GPCR signaling indirectly, impacting Olr419. | ||||||
Valsartan | 137862-53-4 | sc-220362 sc-220362A sc-220362B | 10 mg 100 mg 1 g | $40.00 $92.00 $122.00 | 4 | |
Angiotensin II receptor antagonist, may indirectly affect GPCR signaling, impacting Olr419. | ||||||